Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma
Journal of Medicinal Chemistry · 23.03.2023 · 66 (6) · 3934-3952
DOI: 10.1021/acs.jmedchem.2c01798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 24.02.2023. Verfasst von Zhibin Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Nanjing University of Chinese Medicine, National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Immunogenic cell death (ICD) is a promising direction of cancer immunotherapy in hepatocellular carcinoma (HCC). A series of novel NHC-Au(I) complexes derived from 4,5-diarylimidazole, containing glycyrrhetinic acid (GA) as an efficient targeting ligand for HCC, were herein designed and synthesized. Among these, complex 4C exhibited excellent effectiveness for tumor targeting and antitumor activity, which induced the occurrence of ICD in HCC cells. Additionally, 4C can effectively inhibit TrxR enzyme activity, increase reactive oxygen species (ROS) expression, lead to redox homeostasis disorder, mediate mitochondrial dysfunction and endoplasmic reticulum stress (ERS), and cause the characteristic discharge of damage-associated molecular patterns (DAMPs) in HCC cells. More importantly, 4C showed a great ICD-inducing effect in a vaccination mouse model and activated antitumor immunity in a tumor-bearing C57BL/6 mouse model, which is consistent with the in vitro results. In conclusion, we found the potential of Au(I) complex with HCC-targeted capability for effective tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, P. R. China.
- Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Dali 671000, P. R. China.
- State Key Laboratory of Coordination Chemistry, Nanjing University, Nanjing 210023, P. R. China.
ORCID-Profile: Wukun Liu
Förderung
- Nanjing University of Chinese Medicine
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Province Graduate Practice Innovation Program
- “Innovative and Entrepreneurial Team” Program of Jiangsu Province
Zitieren
APA
Yang, Z., Bian, M., Lv, L., Chang, X., Wen, Z., Li, F., Lu, Y., & Liu, W. (2023). Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma. Journal of Medicinal Chemistry, 66(6), 3934-3952. https://doi.org/10.1021/acs.jmedchem.2c01798
Vancouver
Yang Z, Bian M, Lv L, Chang X, Wen Z, Li F, et al. Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 2023;66(6):3934-3952. doi:10.1021/acs.jmedchem.2c01798
BibTeX
@article{Yang2023,
author = {Yang, Zhibin and Bian, Mianli and Lv, Lin and Chang, Xingyu and Wen, Zhenfan and Li, Fuwei and Lu, Yunlong and Liu, Wukun},
title = {Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {6},
pages = {3934--3952},
doi = {10.1021/acs.jmedchem.2c01798}
}
EUVIMED